Latest Breaking News On - Deficiency cellular therapy program - Page 1 : vimarsana.com

LONDON and REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical stage.

City ofUnited kingdomUnited statesJackie parkinChristine foxLee rothSteven pavleticDenise scots knightMereo biopharmaUltragenyx pharmaceutical incNational cancer instituteNational institutes of healthMereo biopharma groupOncologie incOncxerna therapeutics incExchange commission